COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 1615: Articles 16141-16150  | Next

Homo-harringtonine (HHT) - A highly effective drug against coronaviruses and the potential for large-scale clinical applications
Wen, H.-J., Lin, P., Zhong, G.-X., Xu, Z.-C., Shuai, L., Wen, Z.-Y., Wang, C., Cao, X., He, W.-B., Feng, J., Cai, Q.-C., Ma, H.-J., Wu, S.-J., Wang, G.-D., Lyu, X.-M., Liu, F.-L., Zheng, Y.-T., Zeng, H., He, X.-L., Chen, H.-L., Zhang, F.-J., Wu, C.-I.
10.1101/2021.04.16.440104 — Posted: 2021-04-16
Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2
Zhang, J., Zhang, Y., Kang, J., Chen, S., He, Y., Han, B., Liu, M., Lu, L., Li, L., Yi, Z., Chen, L.
10.1101/2021.04.16.440141 — Posted: 2021-04-16 Discussion: Onsite
SARS-CoV-2 spike protein expressing epithelial cells promotes senescence associated secretory phenotype in endothelial cells and increased inflammatory response
Meyer, K., Patra, T., Mahantesh, V., Ray, R.
10.1101/2021.04.16.440215 — Posted: 2021-04-16
Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.
Stankov, M., Cossmann, A., Bonifacius, A., Jablonka, A., Morillas Ramos, G., Goedecke, N., Zychlinsky Scharff, A., Happle, C., Boeck, A.-L., Tran, A. T., Pink, I., Hoeper, M. M., Blasczyk, R., Winkler, M., Nehlmeier, I., Kempf, A., Hofmann-Winkler, H., Hoffmann, M., Eiz-Vesper, B., Poehlmann, S., Behrens, G.
10.1101/2021.04.16.21255412 — Posted: 2021-04-16
SARS-CoV-2 RNA load in the lower respiratory tract, viral RNAemia and N-antigenemia in critically ill adult COVID-19 patients: relationship with biomarkers of disease severity
Olea, B., Albert, E., Torres, I., Gozalvo-Rovira, R., Carbonell, E., Ferreres, J., Poujois, S., Costa, R., Colomina, J., Rodriguez, J., Blasco, M. L., Navarro, D.
10.1101/2021.04.16.21255601 — Posted: 2021-04-16
Longitudinal detection of SARS-CoV-2-specific antibody responses with different serological methods
Emmerich, P., von Possel, R., Hemmer, C. J., Fritzsche, C., Geerdes-Fenge, H., Menge, B., Messing, C., Borchardt-Lohoelter, V., Deschermeier, C., Steinhagen, K.
10.1101/2021.04.16.21255608 — Posted: 2021-04-16
Modeling non-pharmaceutical interventions in the COVID-19 pandemic with survey-based simulations
Kaffai, M., Heiberger, R. H.
10.1101/2021.04.16.21255606 — Posted: 2021-04-16
Changes in eating habits and sedentary behavior during the COVID-19 pandemic in adolescents with chronic conditions
Mazzolani, B. C., Smaira, F. I., Astley, C., Iraha, A. Y., Pinto, A. J., Marques, I. G., Amarante, M. C., Rezende, N. S., Sieczkowska, S. M., Franco, T. C., Miranda, L. C. d. A., Lindoso, L., Helito, A. C., Oba, J., Queiroz, L. B., Pereira, R. M. R., Roschel, H., Silva, C. A., Gualano, B.
10.1101/2021.04.16.21255582 — Posted: 2021-04-16
More than a year after the onset of the CoVid-19 pandemic in the UK: lessons learned from a minimalistic model capturing essential features including social awareness and policy making
Duran-Olivencia, M. A., Kalliadasis, S.
10.1101/2021.04.15.21255510 — Posted: 2021-04-16
SARS-CoV-2 Immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021: Implications for vaccination policy
Abu Jabal, K., Ben Amram, H., Beiruti, K., Brimat, I., Abu Saada, A., Bathish, Y., Sussan, C., Zarka, S., Edelstein, M.
10.1101/2021.04.11.21255273 — Posted: 2021-04-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).